Steve Byrne analyst BAML

Currently out of the existing stock ratings of Steve Byrne, 108 are a HOLD (27.34%), 84 are a SELL (21.27%), 203 are a BUY (51.39%).

Steve Byrne

Work Performance Price Targets & Ratings Chart

Analyst Steve Byrne, currently employed at BAML, carries an average stock price target met ratio of 58.33% that have a potential upside of 22.49% achieved within 266 days.

Steve Byrne’s has documented 760 price targets and ratings displayed on 46 stocks. The coverage is on Basic Materials, Consumer Defensive, Healthcare, Technology sectors.

Most recent stock forecast was given on CE, Celanese at 29-Jun-2026.

Wall Street Analyst Steve Byrne

Analyst best performing recommendations are on INVA (INNOVIVA).
The best stock recommendation documented was for INVA (INNOVIVA) at 2/19/2015. The price target of $17 was fulfilled within 1 day with a profit of $0.68 (4.17%) receiving and performance score of 41.67.

Average potential price target upside

ALB Albemarle Corp CE Celanese CF CF Industries Holdings CTVA Corteva DD Dupont De Nemours FMC FMC HUN Huntsman LIN Linde plc Ordinary Shares LTHM Livent Corp LYB LyondellBasell Industries NV MOS The Mosaic Company NTR Nutrien Ltd OLN Olin RPM RPM International SHW Sherwin-Williams Co WLK Westlake Chemical APD Air Products and Chemicals BG Bunge ECL Ecolab PPG PPG Industries UNVR Univar VNTR Venator Materials PLC ADM Archer-Daniels-Midland Company AXTA Axalta Coating Systems Ltd GPRE Green Plains Renewable Energy ORGN Origin Materials DOW Dow MNKD MannKind Corp PCRX Pacira Pharmaceuticals SRPT Sarepta Therapeutics EMN Eastman Chemical Company CC Chemours Co ESI Element Solutions WLKP Westlake Chemical Partners LP INVA Innoviva OREX Orexigen Therapeutics PE Parsley Energy ALKS Alkermes Plc ARNA Arena Pharmaceuticals DSEY Diversey Holdings Ltd MGNX MacroGenics RPRX Royalty Pharma Plc SGEN Seagen SGML Sigma Lithium Resources Corp TROX Tronox Holdings PLC VNT Vontier Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 03-Jan-2024

$130

$24.97 (23.77%)

$185

Hold Since 27-Feb-2023

$140

$34.97 (33.30%)

1 months 7 days ago
(24-Aug-2026)

6/8 (75%)

$7.27 (5.48%)

10

Buy Since 13-May-2026

$190

$84.97 (80.90%)

$200

1 months 22 days ago
(09-Aug-2026)

5/10 (50%)

$59.23 (45.29%)

310

Buy Since 09-May-2022

$157

$51.97 (49.48%)

$257

1 months 22 days ago
(09-Aug-2026)

34/47 (72.34%)

$26.23 (20.06%)

467

Buy Since 25-Mar-2026

$225

$119.97 (114.22%)

$245

1 months 25 days ago
(06-Aug-2026)

7/15 (46.67%)

$94.33 (72.19%)

123

Show more analysts

Please expand the browser size to see the chart

Which stock is Steve Byrne most bullish on?

Potential upside of $18.63 has been obtained for CE (CELANESE)

Which stock is Steve Byrne most reserved on?

Potential downside of -$9.47 has been obtained for LYB (LYONDELLBASELL INDUSTRIES NV)

What Year was the first public recommendation made by Steve Byrne?

On 2008
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?